home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

Predisposition Gene For Childhood Cancer

  September, 3 2008 7:24
your information resource in human molecular genetics

A gene responsible for the majority of inherited cases of a common childhood cancer is reported online in Nature. The finding promises to provide a springboard for developing new therapeutic strategies.

Neuroblastoma - a cancer of the nervous system - accounts for 15% of childhood cancer deaths and has bleak survival probabilities of less than 40%. There is a strong familial association and it was predicted over 30 years ago that there was a genetic element to the disease. John Maris and colleagues screened the genomes of 20 affected families, looking for single letter changes in the DNA code or SNPs. They identified inherited mutations in the gene encoding ALK, a tyrosine kinase receptor, as being responsible for causing the disease in the majority of families. Point mutations in this gene were also found in sporadic cases of neuroblastoma. The mutations mapped to a part of the receptor that cause it to be constantly active in promoting cell proliferation, explaining its ability to drive cancer.

The research opens the door for a long-sought-after molecular diagnostic test for predisposition to neuroblastoma, as well as identifying ALK as a promising drug target.

Author contact:

John Maris (The University of Pennsylvania School of Medicine, Philadelphia, PA, USA)
E-mail: maris@chop.edu

Abstract available online.

(C) Nature press release.

Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.